Tanokuchi S - Search Results

1

Decreased creatinine clearance which may be observed during prostaglandin E1 therapy: is it reversible with discontinuation of therapy?

Okada S, Miyai Y, Sato K, Higuchi T, Ichiki K, Tanokuchi S, Ishii K, Hamada H, Ota Z. Okada S, et al. Among authors: tanokuchi s. J Int Med Res. 1991 Nov-Dec;19(6):493-6. doi: 10.1177/030006059101900610. J Int Med Res. 1991. PMID: 1773910

2

Does a dose of 40 micrograms/day prostaglandin E1 reduce creatinine clearance in a patient with diabetic nephropathy of the nephrotic type?

Okada S, Hamada H, Ichiki K, Tanokuchi S, Ishii K, Ota Z, Hiraki Y. Okada S, et al. Among authors: tanokuchi s. J Int Med Res. 1992 Apr;20(2):190-6. doi: 10.1177/030006059202000211. J Int Med Res. 1992. PMID: 1521675

3

Influence of prostaglandin E1 on slight proteinuria in non-azotaemic diabetics.

Okada S, Sato K, Higuchi T, Ichiki K, Tanokuchi S, Ishii K, Hamada H, Ota Z. Okada S, et al. Among authors: tanokuchi s. J Int Med Res. 1992 Feb;20(1):94-7. doi: 10.1177/030006059202000111. J Int Med Res. 1992. PMID: 1568524

4

Effect of prostaglandin E1 on renal haemodynamics in a patient with diabetic nephropathy.

Okada S, Ogino Y, Ichiki K, Tanokuchi S, Ishii K, Hamada H, Ota Z, Hiraki Y. Okada S, et al. Among authors: tanokuchi s. J Int Med Res. 1991 Nov-Dec;19(6):497-500. doi: 10.1177/030006059101900611. J Int Med Res. 1991. PMID: 1773911

5

Influence of prostaglandin E1 on heavy proteinuria in slightly azotaemic diabetics.

Okada S, Sato K, Higuchi T, Ichiki K, Tanokuchi S, Ishii K, Hamada H, Ota Z. Okada S, et al. Among authors: tanokuchi s. J Int Med Res. 1991 Mar-Apr;19(2):171-3. doi: 10.1177/030006059101900212. J Int Med Res. 1991. PMID: 1864454

6

Complement activation via the alternative pathway in a patient with insulin-dependent diabetes mellitus.

Okada S, Ichiki K, Tanokuchi S, Ishii K, Hamada H, Yamamoto H, Ota Z. Okada S, et al. Among authors: tanokuchi s. J Int Med Res. 1991 Jul-Aug;19(4):348-50. doi: 10.1177/030006059101900408. J Int Med Res. 1991. PMID: 1916009

7

Does protease inhibitor inhibit complement activation caused by the immune complex associated with islet cell surface antibody?

Okada S, Sato K, Ichiki K, Tanokuchi S, Ishii K, Ota Z, Takeda A. Okada S, et al. Among authors: tanokuchi s. J Int Med Res. 1991 May-Jun;19(3):234-6. doi: 10.1177/030006059101900309. J Int Med Res. 1991. PMID: 1936512

8

Relationship between cardiosympathetic neuropathy and diabetic somatic neuropathy in patients with non-insulin-dependent diabetes mellitus.

Okada S, Ishii K, Tanokuchi S, Ichiki K, Hamada H, Ogino Y, Ota Z, Shimizu M, Hiraki Y. Okada S, et al. Among authors: tanokuchi s. J Int Med Res. 1995 Jul-Aug;23(4):228-33. doi: 10.1177/030006059502300402. J Int Med Res. 1995. PMID: 7589765

9

Effect of an alpha-glucosidase inhibitor combined with sulphonylurea treatment on glucose metabolism in patients with non-insulin-dependent diabetes mellitus.

Okada S, Ishii K, Tanokuchi S, Hamada H, Ichiki K, Ota Z. Okada S, et al. Among authors: tanokuchi s. J Int Med Res. 1995 Jul-Aug;23(4):279-83. doi: 10.1177/030006059502300408. J Int Med Res. 1995. PMID: 7589771 Clinical Trial.

10

No effect of an alpha-glucosidase inhibitor on glucose metabolism in patients with non-insulin-dependent diabetes mellitus and low function of pancreatic beta cells.

Okada S, Ishii K, Tanokuchi S, Hamada H, Ichiki K, Ota Z. Okada S, et al. Among authors: tanokuchi s. J Int Med Res. 1995 Jul-Aug;23(4):294-8. doi: 10.1177/030006059502300410. J Int Med Res. 1995. PMID: 7589773 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters